Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 4366-4369, October 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, H.
Right arrow Articles by Wright, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, H.
Right arrow Articles by Wright, J. A.

Suppression of Malignancy by the 3' Untranslated Regions of Ribonucleotide Reductase R1 and R2 Messenger RNAs1

Huizhou Fan, Cristy Villegas, Aiping Huang and Jim A. Wright2

Manitoba Institute of Cell Biology and The University of Manitoba, 100 Olivia Street, Winnipeg. Manitoba, R3E 0V9 Canada [H. F., C. V., A. H., J. A. W.]

Mammalian ribonucleotide reductase is rate limiting for the synthesis of DNA. The active enzyme is composed of two dissimilar components called R1 and R2, encoded by different genes. The 3' untranslated regions (3' UTRs) of R1 and R2 messages contain sequences that are important in regulating gene expression through changes in message stability. We have constructed expression plasmids containing the R1 or R2 mRNA 3' UTRs, and we show that transfection of these plasmids into highly malignant mouse 10T1/2 cells significantly suppresses the tumorigenic properties of these cells in syngeneic mice when compared with cells transfected with the same plasmid lacking R1 or R2 3' UTR sequences or when compared with cells transfected with the same plasmid expressing a heterologous sequence as a control. Furthermore, cells expressing the R2 3' UTR exhibit significantly reduced potential to disseminate to the lungs of syngeneic animals in experimental metastasis assays. The tumor-suppressive effects of the mouse R1 and R2 3' UTRs were not confined to mouse cells, because human HeLa cells transfected with expression plasmids containing either R1 or R2 3' UTRs were also significantly less tumorigenic in assays using BALB/c nu/nu mice. These studies demonstrate that the untranslated regions of ribonucleotide reductase mRNAs can function as modifiers of tumor cell development and for the more complex process of tumor dissemination. We propose that these malignancy-suppressive effects are mediated through RNA interactions with cellular components involved in growth regulation through mechanisms of posttranscriptional control of gene expression. In addition, these observations emphasize the enormous potential of untranslated RNA to act directly as modifiers of biological characteristics relevant to mechanisms of malignancy.

1 This work was supported by the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council of Canada (to J. A. W.) and by a postdoctoral fellowship from the Medical Research Council of Canada (to H. F.). J. A. W. is a Terry Fox Senior Scientist of the National Cancer Institute of Canada.

2 To whom requests for reprints should be addressed. Phone: (204) 787-4128; Fax: (204) 787-2190.

Received 2/ 5/96. Accepted 8/14/96.




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
H. Wang, Y. Wang, L. Sun, and D. Liu
Sequences near both termini of the C/EBP{beta} mRNA 3' untranslated region are important for its tumor suppression activity
Acta Biochim Biophys Sin, June 1, 2009; 41(6): 456 - 463.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. A. Desai, R. L. Schilsky, A. Young, L. Janisch, W. M. Stadler, N. J. Vogelzang, S. Cadden, J. A. Wright, and M. J. Ratain
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors
Ann. Onc., June 1, 2005; 16(6): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Manjeshwar, D. E. Branam, M. R. Lerner, D. J. Brackett, and E. R. Jupe
Tumor Suppression by the Prohibitin Gene 3'Untranslated Region RNA in Human Breast Cancer
Cancer Res., September 1, 2003; 63(17): 5251 - 5256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Shchors, F. Yehiely, R. K. Kular, K. U. Kotlo, G. Brewer, and L. P. Deiss
Cell Death Inhibiting RNA (CDIR) Derived from a 3'-Untranslated Region Binds AUF1 and Heat Shock Protein 27
J. Biol. Chem., November 27, 2002; 277(49): 47061 - 47072.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. B. Yeap, R. G. Krueger, and P. J. Leedman
Differential Posttranscriptional Regulation of Androgen Receptor Gene Expression by Androgen in Prostate and Breast Cancer Cells
Endocrinology, July 1, 1999; 140(7): 3282 - 3291.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
A. Stutz, B. Conne, J. Huarte, P. Gubler, V. Völkel, P. Flandin, and J.-D. Vassalli
Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes
Genes & Dev., August 15, 1998; 12(16): 2535 - 2548.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.